The new mRNA cancer vaccine, produced individually for each patient, reduces the risk of death by 42 percent and marks an important turning point in oncology. #mRNAvaktsiin #melanoom #vähiuuringud (translated)
pmo.ee
LÄBIMURRE ⟩ Uus mRNA-vähivaktsiin vähendab surmariski 42 protsenti
